Evereden announces close of Series C funding round


Evereden announces close of Series C funding round

Evereden announces close of Series C funding round

The premium, clean multi-generational skincare brand to bolster growth trajectory 

New York, Dec. 2, 2021 -- Evereden, the fastest growing premium multi-generational skincare brand formulated by Stanford & Harvard dermatologists, announced today that it has raised $32M in Series C funding to continue reinventing the family skincare category and paving the path for much-needed clean, efficacious family skincare products formulated with the highest-quality ingredients. With 38 total SKUs across five key categories – baby, kids, mom, SPF and targeted solutions/medical skincare – Evereden has experienced explosive 350% year over year growth and will continue on this growth trajectory with this latest funding round.  

Led by one of the world’s most successful early-stage venture firms, GSR Ventures, the brand will scale expansion into new markets and sales channels and strengthen its in-house R&D and formulation lab capabilities. In 2022, Evereden will deepen its presence in retail, specifically by launching globally in select markets at Sephora. 

“Evereden has created a category of one in the skincare space by pairing innovation inspired by luxury beauty for families everywhere,” says Richard Lim, founder and Managing Director of GSR Ventures, “The brand is bringing sensibility to family skincare in the most thoughtful way with effective, science-backed products created by mothers who work in medicine.”

The company has a proven track record in being first to market and innovating in truly new categories, such as the Kids Line, which launched 6 months ago and already comprises nearly 20 percent of Evereden’s total revenue as it caters to an underserved market. 

“Our ability to grow and scale quickly is tied closely to our in-house R&D and product development capabilities,” noted Evereden Co-Founder and CEO Kimberley Ho, “We are motivated to continue to create and deliver products that families are excited to use at a pace that keeps up with the demand.” 

All of Evereden’s product formulations are developed with the help of world-renowned Ivy League dermatologists and moms that make up its Moms in Medicine™ team, including Evereden Chief Scientific Officer, Head of Pediatric Dermatology, Stanford Medical School Dr. Joyce Teng, MD, PhD, Evereden Scientific Officer, Professor of Dermatology, Harvard Medical School Dr. Sarina Elmariah, MD, PhD and Evereden Scientific Officer, Instructor of Dermatology, Harvard Medical School Dr. Rebecca Hartman, MD, PhD.

“My mission in launching Evereden is to continue reimagining children and family skincare in a safe and effective way to promote the healthiest futures for all,” says Ho, “We’ve had tremendous success out of the gate, but we are only just beginning.”

For more information, please visit ever-eden.com.

About Evereden:

Evereden is the #1 premium, clean, multi-generational skincare brand globally, formulated by Stanford & Harvard dermatologists to reimagine skincare for the next generation of families. Evereden’s formulas for moms, babies, and kids are exceedingly safe. They nourish, nurture, and give skin everything it needs to reach its full potential during all of life’s most delicate stages. The brand lives by two universal truths: everything that touches your family’s skin has the potential to create a lasting impact on its health. And there’s no such thing as being too safe, exacting or thoughtful when it comes to getting skincare right and ensuring the healthiest futures for you and your family.